Samsung Medical Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Samsung Medical Center takes part in 5 sessions at ESMO 2026 in Madrid. Its sessions centre on antibody-drug conjugates, from managing their side effects to their use in upper gastrointestinal cancer, alongside sequencing targeted therapy in hormone-driven metastatic breast cancer. It also presents phase II results for immunotherapy plus chemotherapy before surgery in high-grade salivary gland carcinoma, and for rivoceranib in thymic tumours.
| Organization | ESMO 2026 Attendance |
|---|---|
Samsung Medical Center Seoul, Republic of Korea | |
Private university hospital in Seoul, Republic of Korea, affiliated with Sungkyunkwan University School of Medicine, with a cancer centre. | Chair Sat Oct 24 12:00–12:50 What oncologists should know about managing toxicities of novel therapies Nursing & supportive care Talk Sat Oct 24 12:30–12:45 ADCs Nursing & supportive care Talk Sun Oct 25 14:45–15:10 Abstract Sun Oct 25 15:22–15:27 Talk Mon Oct 26 08:30–08:45 Antibody Drug Conjugates Gastrointestinal cancers Abstract Mon Oct 26 11:02–11:07 |
Instantly find 20 buyers from Samsung Medical Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction